美国之心脏介入装置市场

Abstract

In 2007, the U.S. market for interventional cardiology devices was valued at almost $5 billion, experiencing a small increase over 2006. Drug-eluting stents were the largest segment of the market, followed by coronary closure devices, percutaneous transluminal coronary angioplasty (PTCA) balloons, bare-metal stents, embolic protection devices, interventional guidewires, diagnostic catheters, intravascular ultrasound (IVUS) catheters, and interventional catheters, as depicted in Chart 1-1. From 2007, the U.S. market for interventional cardiology is expected to decrease, with the market limited by the safety concerns over drug-eluting stents.

Table of Contents

EXECUTIVE SUMMARY

• 1.1 U.S. MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
• 1.2 BARE-METAL AND DRUG-ELUTING STENTS
• 1.3 PTCA AND CUTTING BALLOONS
• 1.4 IVUS CATHETERS
• 1.5 INTERVENTIONAL CATHETERS
• 1.6 INTERVENTIONAL GUIDEWIRES
• 1.7 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
• 1.8 EMBOLIC PROTECTION DEVICES
• 1.9 ATHERECTOMY DEVICES
• 1.10 BRACHYTHERAPY CATHETERS
• 1.11 CHRONIC TOTAL OCCLUSION CROSSERS
• 1.12 THROMBECTOMY DEVICES
• 1.13 INTRODUCER SHEATHS: CORONARY AND PERIPHERAL MARKETS
• 1.14 VASCULAR CLOSURE DEVICES
• 1.15 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
• 1.16 LEADING COMPETITORS
• 1.17 POTENTIAL MARKETS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9 STEP METHODOLOGY
  • 2.2.1 Step 1: Project Initiation & Team Selection
  • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  • 2.2.3 Step 3: Preparation for Interviews & Survey Design
  • 2.2.4 Step 4: Performing Primary Research
  • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  • 2.2.6 Step 6: Market Forecasting
  • 2.2.7 Step 7: Identify Strategic Opportunities
  • 2.2.8 Step 8: Final Review and Market Release
  • 2.2.9 Step 9: Customer Feedback and Market Monitoring

U.S. MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES

• 3.1 INTRODUCTION
• 3.2 OVERVIEW OF THE MARKET
• 3.3 MARKET SEGMENTED BY DEVICE TYPE
• 3.4 TREND ANALYSIS BY MARKET SEGMENT
• 3.5 MARKET DRIVERS
  • 3.5.1 Drug-Eluting Stents
  • 3.5.2 New Diagnostic Technologies
  • 3.5.3 Demographics
• 3.6 MARKET LIMITERS
  • 3.6.1 Late-Stent Thrombosis
  • 3.6.2 Chronic Total Occlusions
  • 3.6.3 Price Competition
• 3.7 COMPETITIVE ANALYSIS
• 3.8 MARKET CONCENTRATION
• 3.9 MERGERS AND ACQUISITIONS
  • 3.9.1 Boston Scientific Acquires Guidant
  • 3.9.2 Abbott Laboratories Acquires Guidant' s Interventional Cardiology Division
  • 3.9.3 Johnson & Johnson Agrees to Acquire Conor Medsystems
  • 3.9.4 Future Acquisitions
• 3.10 LITIGATION ISSUES
• 3.11 POTENTIAL MARKETS

BARE-METAL AND DRUG-ELUTING STENTS

• 4.1 INTRODUCTION
• 4.2 POPULATION AT RISK
• 4.3 PROCEDURE NUMBERS
• 4.4 MARKET ANALYSIS & FORECAST
• 4.5 UNITS SOLD
• 4.6 STENT MARKET BY DELIVERY PLATFORM
• 4.7 STENT MARKET BY SIZE
• 4.8 BARE-METAL STENT MARKET
  • 4.8.1 Market Analysis & Forecast
  • 4.8.2 Competitive Analysis
• 4.9 DRUG-ELUTING STENT MARKET
  • 4.9.1 Market Analysis & Forecast
  • 4.9.2 Competitive Analysis
• 4.10 MARKET DRIVERS AND LIMITERS
  • 4.10.1 Market Drivers
  • 4.10.2 The COURAGE Study
  • 4.10.3 Market Limiters
• 4.11 NEW MARKET PARTICIPANTS
  • 4.11.1 Abbott Laboratories
  • 4.11.2 Medtronic
  • 4.11.3 Conor Medsystems
  • 4.11.4 Xtent Inc
  • 4.11.5 Biosensors International
  • 4.11.6 B. Braun
  • 4.11.7 MIV Therapeutics Inc.

PTCA AND CUTTING BALLOON CATHETERS

• 5.1 INTRODUCTION
  • 5.1.1 The Problem of Restenosis
  • 5.1.2 Conventional and Cutting Balloons
• 5.2 MARKET ANALYSIS & FORECAST
• 5.3 MARKET FOR PTCA BALLOONS
  • 5.3.1 Units Sold
  • 5.3.2 Market Analysis & Forecast
  • 5.3.3 Competitive Analysis
• 5.4 MARKET FOR CUTTING BALLOONS
  • 5.4.1 Device Penetration
  • 5.4.2 Market Analysis & Forecast
  • 5.4.3 Competitive Analysis
• 5.5 MARKET DRIVERS AND LIMITERS
  • 5.5.1 Market Drivers
  • 5.5.2 Market Limiters
• 5.6 NEW TECHNOLOGIES - DRUG-COATED BALLOON CATHETERS

BALLOON-INFLATION SYRINGES

• 6.1 MARKET ANALYSIS & FORECAST
• 6.2 MARKET DRIVERS AND LIMITERS
  • 6.2.1 Market Drivers
  • 6.2.2 Market Limiters
• 6.3 COMPETITIVE ANALYSIS

ANGIOPLASTY KITS

• 7.1 MARKET ANALYSIS & FORECAST
• 7.2 MARKET DRIVERS AND LIMITERS
  • 7.2.1 Market Drivers
  • 7.2.2 Market Limiters
• 7.3 COMPETITIVE ANALYSIS

IVUS CATHETERS

• 8.1 INTRODUCTION
  • 8.1.1 Pre-Stenting Application
  • 8.1.2 Post-Stenting Examination
• 8.2 MARKET ANALYSIS & FORECAST
• 8.3 PENETRATION RATE
• 8.4 MARKET DRIVERS AND LIMITERS
  • 8.4.1 Market Drivers
  • 8.4.2 Market Limiters
• 8.5 COMPETITIVE ANALYSIS

INTERVENTIONAL CATHETERS

• 9.1 INTRODUCTION
  • 9.1.1 Support and Guiding Catheters
  • 9.1.2 Important Characteristics
• 9.2 MARKET ANALYSIS & FORECAST
• 9.3 UNITS SOLD
• 9.4 INTERVENTIONAL GUIDING CATHETERS MARKET
  • 9.4.1 Market Analysis & Forecast
• 9.5 INTERVENTIONAL SUPPORT CATHETERS MARKET
  • 9.5.1 Market Analysis & Forecast
• 9.6 MARKET DRIVERS AND LIMITERS
  • 9.6.1 Market Drivers
  • 9.6.2 Market Limiters
• 9.7 COMPETITIVE ANALYSIS

INTERVENTIONAL GUIDEWIRES

• 10.1 INTRODUCTION
  • 10.1.1 Conventional and Specialty Guidewires
  • 10.1.2 Material and Fabrication
• 10.2 MARKET ANALYSIS & FORECAST
• 10.3 UNITS SOLD
• 10.4 CONVENTIONAL GUIDEWIRES MARKET
• 10.5 SPECIALIZED GUIDEWIRES MARKET
• 10.6 MARKET DRIVER AND LIMITERS
  • 10.6.1 Market Drivers
  • 10.6.2 Market Limiters
• 10.7 COMPETITIVE ANALYSIS

EMBOLIC PROTECTION DEVICES

• 11.1 INTRODUCTION
  • 11.1.1 Saphenous Vein Grafts
  • 11.1.2 Protection Mechanism
• 11.2 MARKET ANALYSIS & FORECAST
• 11.3 PENETRATION RATE
• 11.4 TREND ANALYSIS
• 11.5 MARKET DRIVERS AND LIMITERS
  • 11.5.1 Market Drivers
  • 11.5.2 Market Limiters
• 11.6 COMPETITIVE ANALYSIS
  • 11.6.1 Leading Products
  • 11.6.2 Market Share

ATHERECTOMY DEVICES

• 12.1 INTRODUCTION
  • 12.1.1 Atherectomy
  • 12.1.2 Technologies
• 12.2 MARKET ANALYSIS & FORECAST
• 12.3 PENETRATION RATE
• 12.4 TREND ANALYSIS
• 12.5 MARKET DRIVERS AND LIMITERS
  • 12.5.1 Market Drivers
  • 12.5.2 Market Limiters
• 12.6 COMPETITIVE ANALYSIS

BRACHYTHERAPY CATHETERS

• 13.1 INTRODUCTION
  • 13.1.1 The Introduction of Drug-Eluting Stents
• 13.2 MARKET ANALYSIS & FORECAST
• 13.3 PENETRATION RATE
• 13.4 MARKET DRIVERS AND LIMITERS
  • 13.4.1 Market Drivers
  • 13.4.2 Market Limiters
• 13.5 COMPETITIVE ANALYSIS

THROMBECTOMY DEVICES

• 14.1 INTRODUCTION
  • 14.1.1 Thrombosis and Drug-Eluting Stents
• 14.2 MARKET ANALYSIS & FORECAST
• 14.3 PENETRATION RATE
• 14.4 TREND ANALYSIS
• 14.5 MARKET DRIVERS AND LIMITERS
  • 14.5.1 Market Drivers
  • 14.5.2 Market Limiters
• 14.6 COMPETITIVE ANALYSIS

CHRONIC TOTAL OCCLUSION CROSSERS

• 15.1 INTRODUCTION
  • 15.1.1 Crossing Chronic Total Occlusions
  • 15.1.2 Specialized Devices
• 15.2 POTENTIAL MARKET
• 15.3 MARKET ANALYSIS & FORECAST
• 15.4 PENETRATION RATE
• 15.5 TREND ANALYSIS
• 15.6 MARKET DRIVERS AND LIMITERS
  • 15.6.1 Market Drivers
  • 15.6.2 Market Limiters
• 15.7 COMPETITIVE ANALYSIS

INTRODUCER SHEATHS: CORONARY AND PERIPHERAL MARKETS

• 16.1 INTRODUCTION
• 16.2 MARKET ANALYSIS & FORECAST
• 16.3 CORONARY MARKET
  • 16.3.1 Units Sold
  • 16.3.2 Market Analysis & Forecast
• 16.4 PERIPHERAL MARKET
  • 16.4.1 Units Sold
  • 16.4.2 Market Analysis & Forecast
• 16.5 MARKET DRIVERS AND LIMITERS
  • 16.5.1 Market Drivers
  • 16.5.2 Market Limiters
• 16.6 COMPETITIVE ANALYSIS

VASCULAR CLOSURE DEVICES

• 17.1 INTRODUCTION
  • 17.1.1 Manual Compression
  • 17.1.2 Invasive and Non-Invasive Devices
• 17.2 MARKET ANALYSIS & FORECAST
• 17.3 PENETRATION RATE
  • 17.3.1 Diagnostic Procedures
  • 17.3.2 Interventional Procedures
• 17.4 MARKET DRIVERS AND LIMITERS
  • 17.4.1 Market Drivers
  • 17.4.2 Market Limiters
• 17.5 COMPETITIVE ANALYSIS

DIAGNOSTIC CATHETERS AND GUIDEWIRES

• 18.1 INTRODUCTION
  • 18.1.1 Coronary Angiography
• 18.2 MARKET ANALYSIS & FORECAST
• 18.3 DIAGNOSTIC CATHETERS
  • 18.3.1 Market Analysis & Forecast
  • 18.3.2 Units Sold
  • 18.3.3 Units Sold Segmented by Size
  • 18.3.4 Competitive Analysis
• 18.4 DIAGNOSTIC GUIDEWIRES
  • 18.4.1 Market Analysis & Forecast
  • 18.4.2 Units Sold
  • 18.4.3 Competitive Analysis
• 18.5 MARKET DRIVERS AND LIMITERS
  • 18.5.1 Market Drivers
  • 18.5.2 Market Limiters

POTENTIAL MARKETS

• 19.1 INTRODUCTION
  • 19.1.1 PFOs, ASDs, and VSDs
  • 19.1.2 Percutaneous Mitral Valve Repair (PMVR)
  • 19.1.3 Screening and Treatment of Vulnerable Plaque
• 19.2 OVERVIEW OF POTENTIAL MARKETS

PFO, ASD, AND VSD DEVICES

• 20.1 TARGET POPULATION
• 20.2 POTENTIAL MARKET
  • 20.2.1 Market Analysis & Forecast: Best-Case Scenario
  • 20.2.2 Revenue Probability
• 20.3 COMPETITIVE ANALYSIS
  • 20.3.1 AGA Medical
  • 20.3.2 NMT Medical
  • 20.3.3 St. Jude Medical
  • 20.3.4 W.L. Gore
  • 20.3.5 Cardia Inc.
  • 20.3.6 Cierra Inc

PERCUTANEOUS MITRAL VALVE REPAIR DEVICES

• 21.1 TARGET POPULATION
• 21.2 POTENTIAL MARKET
  • 21.2.1 Market Analysis & Forecast: Best-Case Scenario
  • 21.2.2 Revenue Probability
• 21.3 COMPETITIVE ANALYSIS
  • 21.3.1 Evalve
  • 21.3.2 Edward Lifesciences
  • 21.3.3 Cardiac Dimensions
  • 21.3.4 Mitralign
  • 21.3.5 Viacor

VULNERABLE PLAQUE DEVICES

• 22.1 TARGET POPULATION
• 22.2 POTENTIAL MARKET: BEST-CASE SCENARIO
• 22.3 SCREENING MARKET
  • 22.3.1 Market Analysis & Forecast: Best-Case Scenario
  • 22.3.2 Revenue Probability
• 22.4 INTERVENTIONAL MARKET
  • 22.4.1 Market Analysis & Forecast: Best-Case Scenario
  • 22.4.2 Revenue Probability
• 22.5 COMPETITIVE ANALYSIS
  • 22.5.1 Volcano Therapeutics
  • 22.5.2 Bristol-Myers Squibb
  • 22.5.3 Medeikon
  • 22.5.4 Cryocath
  • 22.5.5 Miravant Technologies
  • 22.5.6 Boston Scientific
  • 22.5.7 Abbott Laboratories
  • 22.5.8 Cordis
  • 22.5.9 Medtronic

ABBREVIATIONS

LIST OF FIGURES

• Figure 3-1 U.S. Market for Interventional Cardiology Segmented by Device Type, 2003 - 2013
• Figure 3-2 Trend Analysis by Market Segment, Growth Rates of the U.S. Market for Interventional Cardiology, 2003 - 2013
• Figure 3-3 Market Drivers, U.S. Market for Interventional Cardiology, 2006
• Figure 3-4 Market Limiters, U.S. Market for Interventional Cardiology, 2006
• Figure 3-5 Leading Competitors by Market Segment, U.S. Market for Interventional Cardiology, 2006
• Figure 3-6 Market Concentration based on the Herfindahl Index, U.S. Market for Interventional Cardiology, 2003 - 2013
• Figure 3-7 Potential U.S. Markets for Interventional Cardiology Devices
• Figure 4-1 Angiography and Angioplasty Procedures, U.S., 2003 - 2013
• Figure 4-2 U.S. Market for Coronary Stents by Type, 2003 - 2013
• Figure 4-3 Units Sold, U.S. Market for Coronary Stents, 2003 - 2013
• Figure 4-4 U.S. Market for Coronary Stents by Delivery Platform, Units Sold, 2003 - 2013
• Figure 4-5 U.S. Market for Coronary Stents by Size, Units Sold, 2006
• Figure 4-6 U.S. Market for Bare-Metal Stents, 2003 - 2013
• Figure 4-7 Leading Competitors, U.S. Market for Bare-Metal Stents, 2006
• Figure 4-8 U.S. Market for Drug-Eluting Stents, 2003 - 2013
• Figure 4-9 Leading Competitors, U.S. Market for Drug-Eluting Stents, 2006
• Figure 4-10 Market Drivers, U.S. Market for Coronary Stents, 2006
• Figure 4-11 Market Limiters, U.S. Market for Coronary Stents, 2006
• Figure 4-12 New Market Participants, U.S. Market for Coronary Stents, 2006
• Figure 5-1 U.S. Market for PTCA and Cutting Balloon Catheters, 2003 - 2013
• Figure 5-2 Units Sold, U.S. Market for PTCA Balloon Catheters, 2003 - 2013
• Figure 5-3 U.S. Market for PTCA Balloon Catheters, 2003 - 2013
• Figure 5-4 Leading Competitors, U.S. Market for PTCA Balloon Catheters, 2006
• Figure 5-5 Units Sold, U.S. Market for Cutting Balloon Catheters, 2003 - 2013
• Figure 5-6 U.S. Market for Cutting Balloon Catheters, 2003 - 2013
• Figure 5-7 Leading Competitor, U.S. Market for Cutting Balloon Catheters, 2006
• Figure 5-8 Market Drivers and Limiters, U.S. Market for PTCA and Cutting Balloon Catheters, 2006
• Figure 6-1 U.S. Market for Balloon-Inflation Syringes, 2003 - 2013
• Figure 6-2 Market Drivers and Limiters, U.S. Market for Balloon-Inflation Syringes, 2006
• Figure 6-3 Leading Competitors, Market for Balloon-Inflation Syringes, 2006
• Figure 7-1 U.S. Market for Angioplasty Accessory Kits, 2003 - 2013
• Figure 7-2 Market Drivers and Limiters, U.S. Market for Angioplasty Accessory Kits, 2003 - 2013
• Figure 7-3 Leading Competitors, U.S. Market for Angioplasty Accessory Kits, 2003 - 2013
• Figure 8-1 U.S. Market for IVUS Catheters, 2003 - 2013
• Figure 8-2 Penetration Rate, U.S. Market for IVUS Catheters, 2003 - 2013
• Figure 8-3 Market Drivers and Limiters, U.S. Market for IVUS Catheters, 2003 - 2013
• Figure 8-4 Leading Competitors, U.S. Market for IVUS Catheters, 2003 - 2013
• Figure 9-1 U.S. Market for Interventional Coronary Catheters by Device Type, 2003 - 2013
• Figure 9-2 Units Sold, U.S. Market for Interventional Coronary Catheters, 2003 - 2013
• Figure 9-3 U.S. Market for Interventional Guiding Catheters, 2003 - 2013
• Figure 9-4 U.S. Market for Interventional Support Catheters, 2003 - 2013
• Figure 9-5 Market Drivers and Limiters, U.S. Market for Interventional Coronary Catheters, 2006
• Figure 9-6 Leading Competitors, U.S. Market for Interventional Coronary Catheters, 2006
• Figure 10-1 U.S. Market for Interventional Coronary Guidewires by Device Type, 2003 - 2013
• Figure 10-2 Units Sold, U.S. Market for Interventional Coronary Guidewires, 2003 - 2013
• Figure 10-3 U.S. Market for Interventional Coronary Conventional Guidewires, 2003 - 2013
• Figure 10-4 U.S. Market for Interventional Coronary Specialized Guidewires, 2003 - 2013
• Figure 10-5 Market Drivers and Limiters, U.S. Market for Interventional Coronary Guidewires, 2006
• Figure 10-6 Leading Competitors, U.S. Market for Interventional Coronary Guidewires, 2006
• Figure 11-1 U.S. Market for Coronary Embolic Protection Devices, 2003 - 2013
• Figure 11-2 Penetration Rate, U.S. Market for Coronary Embolic Protection Devices, 2003 - 2013
• Figure 11-3 Market Drivers and Limiters, U.S. Market for Coronary Embolic Protection Devices, 2006
• Figure 11-4 Leading Competitors, U.S. Market for Coronary Embolic Protection Devices, 2006
• Figure 12-1 U.S. Market for Coronary Atherectomy Devices, 2003 - 2013
• Figure 12-2 Penetration Rate, U.S. Market for Coronary Atherectomy Devices, 2003 - 2013
• Figure 12-3 Market Drivers and Limiters, U.S. Market for Coronary Artherectomy Devices, 2006
• Figure 12-4 Leading Competitors, U.S. Market for Coronary Atherectomy Devices, 2006
• Figure 13-1 U.S. Market for Coronary Brachytherapy Catheters, 2003 - 2013
• Figure 13-2 Penetration Rate, U.S. Market for Coronary Brachytherapy Catheters, 2003 - 2013
• Figure 13-3 Market Drivers and Limiters, U.S. Market for Coronary Brachytherapy Catheters, 2006
• Figure 13-4 Leading Competitors, U.S. Market for Coronary Brachytherapy Catheters, 2006
• Figure 14-1 U.S. Market for Coronary Thrombectomy Devices, 2003 - 2013
• Figure 14-2 Penetration Rate, U.S. Market for Coronary Thrombectomy Devices, 2003 - 2013
• Figure 14-3 Market Drivers and Limiters, U.S. Market for Coronary Thrombectomy Devices, 2006
• Figure 14-4 Leading Competitors, U.S. Market for Coronary Thrombectomy Devices, 2006
• Figure 15-1 Potential Market for Chronic Total Occlusion Crossers, U.S. Market for Interventional Cardiology, 2003 - 2013
• Figure 15-2 U.S. Market for Coronary Chronic Total Occlusion Crossers, 2003 - 2013
• Figure 15-3 Penetration Rate, U.S. Market for Coronary Chronic Total Occlusion Crossers, 2003 - 2013
• Figure 15-4 Market Drivers and Limiters, U.S. Market for Coronary Chronic Total Occlusion Crossers, 2006
• Figure 15-5 Market Players, U.S. Market for Coronary Chronic Total Occlusion Crossers, 2006
• Figure 16-1 U.S. Peripheral and Coronary Markets for Introducer Sheaths, 2003 - 2013
• Figure 16-2 Units Sold, U.S. Coronary Market for Introducer Sheaths, 2003 - 2013
• Figure 16-3 U.S. Coronary Market for Introducer Sheaths, 2003 - 2013
• Figure 16-4 Units Sold, U.S. Peripheral Market for Introducer Sheaths, 2003 - 2013
• Figure 16-5 U.S. Peripheral Market for Introducer Sheaths, 2003 - 2013
• Figure 16-6 Market Drivers and Limiters, U.S. Market for Introducer Sheaths, 2006
• Figure 16-7 Leading Competitors, U.S. Market for Introducer Sheaths, 2006
• Figure 17-1 U.S. Market for Coronary Vascular Closure Devices (Invasive and Non-Invasive), 2003 - 2013
• Figure 17-2 Penetration Rate, U.S. Market for Coronary Vascular Closure Devices (Invasive and Non-Invasive), 2003 - 2013
• Figure 17-3 Market Drivers, U.S. Market for Coronary Vascular Closure Devices, 2006
• Figure 17-4 Market Limiters, U.S. Market for Coronary Vascular Closure Devices, 2006
• Figure 17-5 Leading Competitors, U.S. Market for Coronary Vascular Closure Devices, 2006
• Figure 18-1 U.S. Market for Diagnostic Coronary Catheters and Guidewires, 2003 - 2013
• Figure 18-2 U.S. Market for Diagnostic Coronary Catheters, 2003 - 2013
• Figure 18-3 Units Sold, U.S. Market for Diagnostic Coronary Catheters, 2003 - 2013
• Figure 18-4 Units Sold Segmented by Size, U.S. Market for Diagnostic Coronary Catheters, 2003 - 2013
• Figure 18-5 Leading Competitors, U.S. Market for Diagnostic Coronary Catheters, 2006
• Figure 18-6 U.S. Market for Diagnostic Coronary Guidewires, 2003 - 2013
• Figure 18-7 Units Sold, U.S. Market for Diagnostic Coronary Guidewires, 2003 - 2013
• Figure 18-8 Leading Competitors, U.S. Market for Diagnostic Coronary Guidewires, 2006
• Figure 18-9 Market Drivers and Limiters, U.S. Market for Diagnostic Coronary Catheters and Guidewires, 2006
• Figure 19-1 Potential U.S. Markets for Interventional Cardiology, Best-Case Scenario, 2008 - 2013
• Figure 20-1 Target Population, Potential U.S. Market for PFO, ASD, and VSD Devices, 2003 - 2013
• Figure 20-2 Potential U.S. Market for PFO, ASD, and VSD Devices, Best-Case Scenario, 2003 - 2013
• Figure 20-3 Total Revenue, Potential U.S. Market for PFO, ASD, and VSD Devices, Best-Case Scenario, 2008 - 2013
• Figure 20-4 Market Players, Potential U.S. Market for PFO, ASD, and VSD Devices, 2008 - 2013
• Figure 21-1 Target Population, Potential U.S. Market for PMVR Devices, 2009 - 2013
• Figure 21-2 Potential U.S. Market for PMVR Devices, Best-Case Scenario, 2009 - 2013
• Figure 21-3 Total Revenue, Potential U.S. Market for PMVR Devices, Best- Case Scenario, 2009 - 2013
• Figure 21-4 Market Players, Potential U.S. Market for PMVR Devices, 2009 - 2013
• Figure 22-1 Target Population, Potential U.S. Market for Vulnerable Plaque, 2009 - 2013
• Figure 22-2 Potential U.S. Market for Vulnerable Plaque, Best-Case Scenario, 2009 - 2013
• Figure 22-3 Potential U.S. Market for Vulnerable Plaque Screening Devices, Best- Case Scenario, 2009 - 2013
• Figure 22-4 Total Revenue, Potential U.S. Market for Vulnerable Plaque Screening Devices, Best-Case Scenario, 2009 - 2013
• Figure 22-5 Potential U.S. Market for Vulnerable Plaque Interventional Devices, Best- Case Scenario, 2009 - 2013
• Figure 22-6 Total Revenue, Potential U.S. Market for Vulnerable Plaque Interventional Devices, Best-Case Scenario, 2009 - 2013
• Figure 22-7 Market Players, Potential U.S. Market for Vulnerable Plaque Devices, 2009 - 2013

LIST OF CHARTS

• Chart 1-1 U.S. Market for Interventional Cardiology by Segment, 2006
• Chart 1-2 U.S. Market for Coronary Stents, 2003 -2013
• Chart 1-3 U.S. Market for PTCA and Cutting Balloons, 2003 - 2013
• Chart 1-4 U.S. Market for IVUS Catheters, 2003 -2013
• Chart 1-5 U.S. Market U.S. Market for Diagnostic Coronary Catheters and Guidewires
• Chart 1-6 Leading Competitors, U.S. Market for Interventional Cardiology, 2006
• Chart 1-7 Potential U.S. Markets for Interventional Cardiology, 2003 - 2013
• Chart 3-1 Market for Interventional Cardiology, 2003 - 2013
• Chart 3-2 U.S. Market for Interventional Cardiology Segmented by Device Type, 2006
• Chart 3-3 Trend Analysis by Market Segment, U.S. Market for Interventional Cardiology, 2003 - 2013
• Chart 3-4 Leading Competitors, U.S. Market for Interventional Cardiology, 2006
• Chart 3-5 Market Concentration based on the Herfindahl Index, U.S. Market for Interventional Cardiology, 2003 - 2013
• Chart 4-1 Population at Risk, U.S. Market for Interventional Cardiology, 2003 - 2013
• Chart 4-2 Age Group Most Likely to Undergo Cardiac Intervention, U.S. Market for Intervention Cardiology, 2003 - 2013
• Chart 4-3 Angioplasty and Angiography Procedures, U.S., 2003 - 2013
• Chart 4-4 U.S. Market for Coronary Stents by Type, 2003 - 2013
• Chart 4-5 U.S. Market for Coronary Stents by Type, Units Sold, 2003 - 2013
• Chart 4-6 U.S. Market for Coronary Stents by Delivery Platform, Units Sold, 2003 - 2013
• Chart 4-7 U.S. Market for Coronary Stents by Size, Units Sold, 2006
• Chart 4-8 U.S. Market for Bare-Metal Stents, 2003 - 2013
• Chart 4-9 U.S. Market for Drug-Eluting Stents, 2003 - 2013
• Chart 5-1 U.S. Market for PTCA and Cutting Balloon Catheters, 2003 - 2013
• Chart 5-2 U.S. Market for PTCA Balloon Catheters, 2003 - 2013
• Chart 5-3 U.S. Market for Cutting Balloon Catheters, 2003 - 2013
• Chart 6-1 U.S. Market for Balloon-Inflation Syringes, 2003 - 2013
• Chart 6-2 Leading Competitors, Market for Balloon-Inflation Syringes, 2006
• Chart 7-1 U.S. Market for Angioplasty Accessory Kits, 2003 - 2013
• Chart 8-1 U.S. Market for IVUS Catheters, 2003 - 2013
• Chart 9-1 U.S. Market for Interventional Coronary Catheters by Device Type, 2003 - 2013
• Chart 10-1 U.S. Market for Interventional Coronary Guidewires by Device Type, 2003 - 2013
• Chart 10-2 U.S. Market for Interventional Coronary Guidewires by Device Type, Units Sold, 2003 - 2013
• Chart 11-1 U.S. Market for Coronary Embolic Protection Devices, 2003 - 2013
• Chart 11-2 CAGRs, U.S. Markets for Peripheral and Coronary Embolic Protection Devices, 2004 - 2011
• Chart 12-1 U.S. Market for Coronary Atherectomy Devices, 2003 - 2013
• Chart 12-2 CAGRs, U.S. Markets for Peripheral and Coronary Atherectomy Devices, 2004 - 2011
• Chart 13-1 U.S. Market for Coronary Brachytherapy Catheters, 2003 - 2013
• Chart 14-1 U.S. Market for Coronary Thrombectomy Devices, 2003 - 2013
• Chart 14-2 CAGRs, U.S. Markets for Peripheral and Coronary Thrombectomy Devices, 2004 - 2011
• Chart 15-1 U.S. Market for Coronary Chronic Total Occlusion Crossers, 2003 - 2013
• Chart 15-2 Penetration Rate, U.S. Market for Coronary Chronic Total Occlusion Crossers, 2003 - 2013
• Chart 15-3 CAGRs, U.S. Markets for Peripheral and Coronary Chronic Total Occlusion Crossers, 2004 - 2011
• Chart 16-1 U.S. Peripheral and Coronary Markets for Introducer Sheaths, 2003 - 2013
• Chart 17-1 U.S. Market for Coronary Vascular Closure Devices, (Invasive and Non- Invasive), 2003 - 2013
• Chart 18-1 U.S. Market for Diagnostic Coronary Catheters and Guidewires, 2003 - 2013
• Chart 18-2 Units Sold Segmented by Size, U.S. Market for Diagnostic Coronary Catheters, 2003 - 2013
• Chart 19-1 Current and Potential Markets for Interventional Cardiology in the U.S., Best- Case Scenario, 2003 - 2013
• Chart 20-1 Revenue Probability, Potential U.S. Market for PFO, ASD, and VSD Devices, 2008 - 2013
• Chart 21-1 Revenue Probability, Potential U.S. Market for PMVR Devices, 2009 - 2013
• Chart 22-1 Potential U.S. Market for Vulnerable Plaque, Best-Case Scenario, 2009 - 2013
• Chart 22-2 Revenue Probability, Potential U.S. Market for Vulnerable Plaque Screening Devices, 2009 - 2013
• Chart 22-3 Revenue Probability, Potential U.S. Market for Vulnerable Plaque Interventional Devices, 2009 - 2013